These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23105595)

  • 1. Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease.
    Ghosh J; Mishra TK; Rao YN; Aggarwal SK
    Indian J Clin Biochem; 2006 Mar; 21(1):181-4. PubMed ID: 23105595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women.
    Carlson LA; Ericsson M
    Atherosclerosis; 1975; 21(3):417-33. PubMed ID: 1148035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease.
    Sharma R; Mahajan M; Kant R
    Indian J Clin Biochem; 2004 Jan; 19(1):10-3. PubMed ID: 23105418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.